Skip to content
healthcare.dev

Ibandronate sodium

NDC 55111-575, Ibandronate sodium, tablet, from Dr. Reddy's Laboratories Limited.

Product NDC
55111-575
Status
Listed
Labeler
Dr. Reddy's Laboratories Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078997
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55111-575 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IBANDRONATE SODIUM150 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
55111-575-03551110575033 BLISTER PACK in 1 CARTON (55111-575-03) / 1 TABLET in 1 BLISTER PACK (55111-575-11)
55111-575-43551110575431 BLISTER PACK in 1 CARTON (55111-575-43) / 3 TABLET in 1 BLISTER PACK (55111-575-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f94d9c49-245a-8081-42c4-785113fce498
  • NADAC price for package 55111057543

    GET /v1/drugs/nadac/55111057543

Use it

Look up 55111-575 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55111-575 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55111-575. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.